Lyophilizable Stem Cell‐Hybrid Liposome with Long‐Term Stability and High Targeting Capacity
Tianyuan Zhang,Xixi Zheng,Ruyi Lin,Hao Sun,Honghui Wu,Jingsong Zhang,Shihan Chen,Yaosheng Li,Donghang Xu,Jianqing Gao
DOI: https://doi.org/10.1002/adhm.202400704
IF: 10
2024-05-25
Advanced Healthcare Materials
Abstract:The hybridization of liposome with stem cell membrane is an emerging technology to prepare the nanovehicle with the capacity of disease‐responsive targeting. However, the long‐term storage of this hybrid liposome has received limited attention in the literature, which is essential for their potential applicability in the clinic. Therefore, the preservation of long‐term activity of stem cell‐hybrid liposome using freeze‐drying is investigated in the present study. Mesenchymal stem cell‐hybrid liposome is synthesized and its feasibility for freeze‐drying under different conditions is examined. Results revealed that pre‐freezing the hybrid liposome at ‐20 °C in Tris buffer solution (pH 7.4) containing 10% trehalose could well preserve the liposomal structure for at least 3 months. Notably, major membrane proteins on the hybrid liposome are protected in this formulation and CXCR4‐associated targeting capacity is maintained both in vitro and in vivo. Consequently, the hybrid liposome stored for 3 months demonstrate a comparable tumor inhibition as the fresh‐prepared ones. The present study provides the first insights into the long‐term storage of stem cell hybrid liposome using lyophilization, which may make an important step forward in enhancing the long‐term stability of these promising biomimetic nanovehicle and ease the logistics and the freeze‐storage in the potential clinical applications. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials